Not sure the statistics agree with you on that .... especially given another 1,847 people died on Tuesday 4th Jan from COVID-19 in the USA alone ?
I think Mesoblast have a great case to lobby either the NIH or a new partner to fund this additional phase 3 COVID-19 ARDS trial that they propose to undertake this year ....
..... almost 4 million new COVID-19 cases in the last 7 days is likely to see hospitalisation and death numbers increase over the coming weeks based on previous lags from case number increases and the situations evolving in many states combined with the winter months now upon the USA
I am all for the additional phase 3 COVID-19 ARDS trial as long as Mesoblast don't have to fund it
https://www.worldometers.info/coronavirus/
https://www.worldometers.info/coronavirus/weekly-trends/#weekly_table
RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-4
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.060(5.85%) |
Mkt cap ! $1.238B | |||
| Open | High | Low | Value | Volume |
| $1.03 | $1.10 | $1.02 | $6.406M | 6.038M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 313712 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.08 |
Change
0.060 ( 5.29 %) |
||||
| Open | High | Low | Volume | ||
| $1.03 | $1.10 | $1.02 | 928883 | ||
| Last updated 15.59pm 17/05/2024 ? | |||||
| MSB (ASX) Chart |